NPPB and congestive heart failure: Biomarkers such as the serum N-terminal pro-brain natriuretic peptide (NT-pro BNP), the New York Heart Association (NYHA) classification, and the left ventricular ejection fraction (LVEF) are integral components of the current evaluation framework for CHF patients [2, 3].